Search Orphan Drug Designations and Approvals
-
| Generic Name: | (R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide |
|---|---|
| Date Designated: | 05/14/2024 |
| Orphan Designation: | treatment of fragile X syndrome |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Spinogenix, Inc. 1901 Avenue of the Stars Suite 200 Los Angeles, California 90067 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







